Esoteric Testing Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2023-2027

Published: Oct 2023 Pages: 153 SKU: IRTNTR76289

Esoteric Testing Market Forecast 2023-2027

The global esoteric testing market size is estimated to grow by USD 18.87 billion at a CAGR of 11.51% between 2022 and 2027. The market's growth is influenced by several key factors, including the rising incidence of chronic diseases, an uptick in new product introductions, and a surge in merger and acquisition endeavors. As chronic conditions become more prevalent, there's a growing need for innovative healthcare solutions to address these challenges. The influx of new products entering the market reflects a dynamic landscape driven by technological advancements and evolving consumer preferences. Additionally, the uptick in merger and acquisition activities indicates a trend toward consolidation and strategic partnerships aimed at enhancing market presence and competitiveness. These factors collectively contribute to the market's growth trajectory, shaping the future of healthcare delivery and patient outcomes.

Esoteric tests are useful in the early detection of chronic diseases. Chronic diseases are one of the leading causes of disability and death worldwide. The three main chronic diseases are cardiovascular disease, chronic obstructive pulmonary disease (COPD), and type 2 diabetes, often caused by high blood pressure (BP), blood cholesterol, and obesity. In addition, chronic diseases such as heart disease, asthma, cancer, and diabetes are generally not curable. These diseases can indeed be prevented and controlled through various measures, including exercise, a healthy diet, and early detection and treatment. Additionally, managed care organizations play a role in providing comprehensive care, and technologies like real-time PCR can aid in early detection. Expanded care delivery models also play a crucial role in ensuring access to preventive and treatment services. These diseases are diagnosed in a clinical laboratory. Hence, the increasing prevalence of chronic diseases will drive the growth of the market during the forecast period.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation

This report provides a detailed analysis of the market by Type (Infectious disease, Endocrinology, Oncology, Immunology, and Others ), End-user (Hospital laboratories, Clinical research laboratories and medical institutes, and Reference laboratories ), and Geography (North America, Europe, Asia, and Rest of World (ROW)).

By Type

Infectious disease

The market share growth by the infectious disease segment will be significant during the forecast period. There has been an increase in the incidence of infectious diseases across the globe. Infectious diseases are caused by organisms such as bacteria, viruses, fungi, and parasites. Globally, infectious disease epidemics increase due to changing lifestyles, leading to reduced immunity. The pattern of infection rates has also changed with the development of drug-resistant pathogens.

Get a glance at the market contribution of various segments View a PDF Sample

The infectious disease segment was valued at USD 5.04 billion in 2017 HIV/AIDS remains the leading cause of death in many countries. According to data from the United Nations Program on HIV/AIDS (UNAIDS), in 2020, around the world, 680,000 people will die from AIDS-related diseases. The incidence of infectious diseases has also decreased in many countries. Globally, the prevalence and incidence of infectious diseases are increasing due to global climate change. This is expected to be the main driver for market growth during the forecast period.

By End-User

Hospital laboratories

The hospital laboratories segment holds the largest share in the market. Esoteric tests play a key role in modern healthcare because they offer significant advantages over conventional tests. The increasing number of patients visiting hospital laboratories for diagnostic purposes is driving the demand for esoteric tests in this segment. The increasing prevalence of chronic diseases and the rising number of diagnostic tests performed in hospital laboratories drive the growth of the hospital laboratories market segment during the forecast period.

By Region

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Factors such as the adoption of advanced technologies coupled with a well-established healthcare infrastructure will drive the growth of the market in the region. Several hospitals and clinics in the area are adopting esoteric testing services to effectively diagnose and treat a rapidly growing number of patients.

Furthermore, the growing number of corporate wellness programs and travel and tourism activities are driving the growth of the market. In the US, many organizations offer healthcare as part of their corporate wellness program, which is increasing the adoption of clinical laboratory services. The growing demand for esoteric tests from government organizations for procedures like visa approval is also driving the growth of the market. Hence, such factors are expected to drive market growth in this region during the forecast period.

Buy Now Full Report and Discover More

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

The University of Utah:  The company offers esoteric testing, such as in-house esoteric testing panels, under the lab called ARUP Laboratories.

  • ATS GENETECH PVT. LTD.
  • Bio Rad Laboratories Inc.
  • Creative Biogene
  • Cytek Biosciences Inc.
  • EMSL Analytical Inc.
  • Enzo Biochem Inc.
  • Intertek Group Plc
  • IQVIA Holdings Inc.
  • Kindstar Globalgene Technology Inc.
  • Laboratory Corp. of America Holdings
  • Machaon Diagnostics Inc.
  • MedGenome Labs Ltd.
  • Merck KGaA
  • Microbac Laboratories Inc.
  • Miltenyi Biotec B.V. and Co. KG
  • Oncquest Laboratories Ltd.
  • Rochester Regional Health
  • Sonic Healthcare Ltd.
  • Yoda Diagnostics

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

Esoteric testing plays a crucial role in precision medicines by enabling early diagnosis of various conditions, including cardiovascular diseases, Dengue, Hepatitis B, Hepatitis C, and rare genetic disorders. This type of testing often involves advanced techniques such as mass spectrometry, enzyme-linked immunosorbent assay, real-time polymerase chain reaction, and multiplexing to analyze hormones, proteins, antibodies, nucleic acids, and other rare molecules. Due to its complexity, esoteric testing requires complex apparatus and trained personnel to perform tests accurately and efficiently. It is commonly used in immunology testing, genetic testing, endocrinology tests, oncology tests, toxicology testing, and neurology testing to provide valuable insights for patient care. Our researchers analyzed the data with 2022 as the base year, along with the key trends and challenges. 

Significant Market Trends

Growing emphasis on expansions of esoteric testing facilities is a primary trend in the market. An increase in the global average age due to an increase in longevity or life expectancy will lead to an increase in the number of elderly people in the world. In addition, advances in medicine and healthcare have resulted in fewer cases of disability. The increase in the elderly population has led to an increase in healthcare costs related to regular health check-ups, disease diagnosis, treatment, and surgery.

Furthermore, the most common problems affecting the aging population are Alzheimer's disease (AD), cardiovascular disease, osteoarthritis, diabetes, and cancer. Since the elderly have weak immunity and metabolism, they need frequent diagnostic testing. This increases the demand for esoteric testing services. As a result, the growing aging population globally, especially in countries like Japan and Italy, will boost the growth of the market during the forecast period.

Major Market Challenges

The lack of skilled clinical laboratory professionals is a challenge that affects the growth of the market. Clinical laboratory specialists are trained and certified professionals who are trained in the theoretical and practical aspects of clinical laboratory processes and procedures. Clinical laboratory professionals play different roles, such as technologists, research technologists, supervisors, administrators, or educators. Approximately 60-70% of all medical decisions regarding admission and discharge, as well as diagnosis and treatment, are determined by the relevant tests and diagnoses performed by laboratory specialists. 

However, there is still a shortage of trained professionals who can handle advanced diagnostic equipment. Lack of expertise increases the likelihood of misdiagnosis. Therefore, it is important to train staff in the use of critical diagnostic equipment. The market is very competitive. Therefore, an accurate diagnosis is essential. Hence, the lack of skilled technicians and lab professionals may impede the growth of the market during the forecast period.

Buy Now Full Report and Discover More

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and analyzes the latest trends and growth opportunities from 2017 to 2027. 

  • Type Outlook 
    • Infectious disease
    • Endocrinology
    • Oncology
    • Immunology
    • Others
  • End-user Outlook 
    • Hospital laboratories
    • Clinical research laboratories and medical institutes
    • Reference laboratories
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World
      • Australia
      • Argentina
      • Brazil 

Market Analyst Overview

The market is critical for diagnosing and monitoring complex diseases such as HIV, Malaria, and Tuberculosis. Advanced technologies like DNA sequencing and NGS technologies, including whole genome sequencing, enable precise analysis. Reimbursement from Medicare, Medicaid, and managed care organizations supports access to these tests. Biomarker analysis using techniques like digital PCR, pyrosequencing, and Sanger sequencing aids in disease detection. Digital microfluidic platforms and molecular phenotyping technologies provide insights for personalized medicine. With an aging population, demand for endocrinology and oncology tests is rising, necessitating chemiluminescence immunoassay, flow cytometry, and real-time PCR for accurate results and improved patient care.

Market Scope

Report Coverage

Details

Page number

153

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 11.51%

Market growth 2023-2027

USD 18.87 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

10.77

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 36%

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks

Key companies profiled

ATS GENETECH PVT. LTD., Bio Rad Laboratories Inc., Creative Biogene, Cytek Biosciences Inc., EMSL Analytical Inc., Enzo Biochem Inc., Intertek Group Plc, IQVIA Holdings Inc., Kindstar Globalgene Technology Inc., Laboratory Corp. of America Holdings, Machaon Diagnostics Inc., MedGenome Labs Ltd., Merck KGaA, Microbac Laboratories Inc., Miltenyi Biotec B.V. and Co. KG, Oncquest Laboratories Ltd., Rochester Regional Health, Sonic Healthcare Ltd., The University of Utah, and Yoda Diagnostics

Market dynamics

Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.

Customization purview

If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
  • Precise estimation of the size of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global esoteric testing market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global esoteric testing market 2017 - 2021 ($ million)
    • 4.2 Type Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)
    • 4.3 End-User Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-User Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Infectious disease - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Infectious disease - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Infectious disease - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Infectious disease - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Infectious disease - Year-over-year growth 2022-2027 (%)
    • 6.4 Endocrinology - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Endocrinology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Endocrinology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Endocrinology - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Endocrinology - Year-over-year growth 2022-2027 (%)
    • 6.5 Oncology - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Oncology - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
    • 6.6 Immunology - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Immunology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Immunology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Immunology - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Immunology - Year-over-year growth 2022-2027 (%)
    • 6.7 Others - Market size and forecast 2022-2027
      • Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.8 Market opportunity by Type
      • Exhibit 54: Market opportunity by Type ($ million)
      • Exhibit 55: Data Table on Market opportunity by Type ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 56: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 57: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 58: Chart on Comparison by End-user
      • Exhibit 59: Data Table on Comparison by End-user
    • 7.3 Hospital laboratories - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Hospital laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Hospital laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Hospital laboratories - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Hospital laboratories - Year-over-year growth 2022-2027 (%)
    • 7.4 Clinical research laboratories and medical institutes - Market size and forecast 2022-2027
      • Exhibit 64: Chart on Clinical research laboratories and medical institutes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Data Table on Clinical research laboratories and medical institutes - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Chart on Clinical research laboratories and medical institutes - Year-over-year growth 2022-2027 (%)
      • Exhibit 67: Data Table on Clinical research laboratories and medical institutes - Year-over-year growth 2022-2027 (%)
    • 7.5 Reference laboratories - Market size and forecast 2022-2027
      • Exhibit 68: Chart on Reference laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 69: Data Table on Reference laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Chart on Reference laboratories - Year-over-year growth 2022-2027 (%)
      • Exhibit 71: Data Table on Reference laboratories - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 72: Market opportunity by End-user ($ million)
      • Exhibit 73: Data Table on Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 75: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 76: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 77: Chart on Geographic comparison
      • Exhibit 78: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 UK - Market size and forecast 2022-2027
      • Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.10 China - Market size and forecast 2022-2027
      • Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.11 Canada - Market size and forecast 2022-2027
      • Exhibit 111: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 112: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 113: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 114: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 115: Market opportunity by geography ($ million)
      • Exhibit 116: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 117: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 119: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 120: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 121: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 122: Matrix on vendor position and classification
            • 12.3 ATS GENETECH PVT. LTD.
              • Exhibit 123: ATS GENETECH PVT. LTD. - Overview
              • Exhibit 124: ATS GENETECH PVT. LTD. - Product / Service
              • Exhibit 125: ATS GENETECH PVT. LTD. - Key offerings
            • 12.4 Creative Biogene
              • Exhibit 126: Creative Biogene - Overview
              • Exhibit 127: Creative Biogene - Product / Service
              • Exhibit 128: Creative Biogene - Key offerings
            • 12.5 Cytek Biosciences Inc.
              • Exhibit 129: Cytek Biosciences Inc. - Overview
              • Exhibit 130: Cytek Biosciences Inc. - Product / Service
              • Exhibit 131: Cytek Biosciences Inc. - Key offerings
            • 12.6 IQVIA Holdings Inc.
              • Exhibit 132: IQVIA Holdings Inc. - Overview
              • Exhibit 133: IQVIA Holdings Inc. - Business segments
              • Exhibit 134: IQVIA Holdings Inc. - Key news
              • Exhibit 135: IQVIA Holdings Inc. - Key offerings
              • Exhibit 136: IQVIA Holdings Inc. - Segment focus
            • 12.7 Kindstar Globalgene Technology Inc.
              • Exhibit 137: Kindstar Globalgene Technology Inc. - Overview
              • Exhibit 138: Kindstar Globalgene Technology Inc. - Product / Service
              • Exhibit 139: Kindstar Globalgene Technology Inc. - Key offerings
            • 12.8 Laboratory Corp. of America Holdings
              • Exhibit 140: Laboratory Corp. of America Holdings - Overview
              • Exhibit 141: Laboratory Corp. of America Holdings - Business segments
              • Exhibit 142: Laboratory Corp. of America Holdings - Key news
              • Exhibit 143: Laboratory Corp. of America Holdings - Key offerings
              • Exhibit 144: Laboratory Corp. of America Holdings - Segment focus
            • 12.9 Machaon Diagnostics Inc.
              • Exhibit 145: Machaon Diagnostics Inc. - Overview
              • Exhibit 146: Machaon Diagnostics Inc. - Product / Service
              • Exhibit 147: Machaon Diagnostics Inc. - Key offerings
            • 12.10 MedGenome Labs Ltd.
              • Exhibit 148: MedGenome Labs Ltd. - Overview
              • Exhibit 149: MedGenome Labs Ltd. - Product / Service
              • Exhibit 150: MedGenome Labs Ltd. - Key offerings
            • 12.11 Merck KGaA
              • Exhibit 151: Merck KGaA - Overview
              • Exhibit 152: Merck KGaA - Business segments
              • Exhibit 153: Merck KGaA - Key news
              • Exhibit 154: Merck KGaA - Key offerings
              • Exhibit 155: Merck KGaA - Segment focus
            • 12.12 Microbac Laboratories Inc.
              • Exhibit 156: Microbac Laboratories Inc. - Overview
              • Exhibit 157: Microbac Laboratories Inc. - Product / Service
              • Exhibit 158: Microbac Laboratories Inc. - Key offerings
            • 12.13 Miltenyi Biotec B.V. and Co. KG
              • Exhibit 159: Miltenyi Biotec B.V. and Co. KG - Overview
              • Exhibit 160: Miltenyi Biotec B.V. and Co. KG - Product / Service
              • Exhibit 161: Miltenyi Biotec B.V. and Co. KG - Key offerings
            • 12.14 Oncquest Laboratories Ltd.
              • Exhibit 162: Oncquest Laboratories Ltd. - Overview
              • Exhibit 163: Oncquest Laboratories Ltd. - Product / Service
              • Exhibit 164: Oncquest Laboratories Ltd. - Key offerings
            • 12.15 Rochester Regional Health
              • Exhibit 165: Rochester Regional Health - Overview
              • Exhibit 166: Rochester Regional Health - Product / Service
              • Exhibit 167: Rochester Regional Health - Key offerings
            • 12.16 Sonic Healthcare Ltd.
              • Exhibit 168: Sonic Healthcare Ltd. - Overview
              • Exhibit 169: Sonic Healthcare Ltd. - Business segments
              • Exhibit 170: Sonic Healthcare Ltd. - Key offerings
              • Exhibit 171: Sonic Healthcare Ltd. - Segment focus
            • 12.17 The University of Utah
              • Exhibit 172: The University of Utah - Overview
              • Exhibit 173: The University of Utah - Product / Service
              • Exhibit 174: The University of Utah - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 175: Inclusions checklist
                • Exhibit 176: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 177: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 178: Research methodology
                • Exhibit 179: Validation techniques employed for market sizing
                • Exhibit 180: Information sources
              • 13.5 List of abbreviations
                • Exhibit 181: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              esoteric testing market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis